REQUEST A DEMO
Total
USD $0.00
Search more companies

Hsa Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hsa Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hsa Pharma Private Limited is an unlisted company, incorporated on 13/06/2012. It has its registered office in the State of Tamil Nadu, India. Company's corporate identification number (CIN) is U24232TN2012PTC086279 and registration number is 086279. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Old No.16, New No.17, 1St Floor, Samanthi Street Brindavan Nagar, Koyembedu
Chennai; Tamil Nadu; Postal Code: 600092

Contact Details: Purchase the Hsa Pharma Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Hsa Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Hsa Pharma Private Limited report to view the information.
Incorporation Date:
June 13, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Hsa Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-9.58%
Total operating revenue
-9.68%
Operating profit (EBIT)
8.3%
EBITDA
-15.42%
Net Profit (Loss) for the Period
2.07%
Total assets
-17.69%
Total equity
15.67%
Operating Profit Margin (ROS)
0.07%
Net Profit Margin
0.04%
Return on Equity (ROE)
-1.8%
Debt to Equity Ratio
-47.37%
Quick Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?